Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - Category: Internal Medicine Authors: Rashmi K. Murthy Sherene Loi Alicia Okines Elisavet Paplomata Erika Hamilton Sara A. Hurvitz Nancy U. Lin Virginia Borges Vandana Abramson Carey Anders Philippe L. Bedard Mafalda Oliveira Erik Jakobsen Thomas Bachelot Shlomit S. Shachar Volkmar M üller S Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | Internal Medicine | Xeloda